NEW YORK, August 6, 2018 /PRNewswire/ -- US, Europe, Japan, Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Others
Read the full report: https://www.reportlinker.com/p05482466
Visiongain forecasts the antibiotic drugs market to increase to $ 43,841.7m in 2022. The market is estimated to grow at a CAGR of 3.4% between 2022 and 2028. In 2017, Pfizer held the largest market share of the antibiotic drugs market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 250-page report you will receive 181 tables and 111 figures-all unavailable elsewhere.
The 250-page report provides clear detailed insight into the top 25 antibiotic drugs manufacturers. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
- Global Antibiotic Drugs Market Forecast from 2018-2028, further segmented by type:
- Cephalosporins
- Penicillins
- Fluoroquinolones
- Macrolides
- Carbapenems
- Others
- This report provides analysis of the leading antibiotic drugs manufacturers in the US, including forecasts from 2018-2028 of the company's antibiotic drugs revenues, where possible:
- Pfizer: Sulperazon, Unasyn, Zithromax, Dalacin, Merrem/Meropen, Zyvox, Tygacil, Others
- Merck & Co.: Cubicin, Invanz, Avelox, Primaxin, Others
- Johnson & Johnson: Zeftera, Sirturo, Others
- Cubist Pharmaceuticals: Cubicin, Sivextro Oral
- Abbott Laboratories: Baxin, Others
- Eli Lilly & Co.: Vancocin, Ceclor
- Melinta Therapeutics, Inc: Orbactiv, Others
- This report provides analysis of the leading antibiotic drugs manufacturers in Europe, including forecasts from 2018-2028 of the company's antibiotic drugs revenues, where possible:
- Novartis: Vigamox, Ciprodex, TOBI Podhaler, Cubicin
- GlaxoSmithKline: Ceftin/Zinnat, Augmentin IR, Amoxil, Others
- Bayer: Avelox, Cipro/Cirpobay
- Allergan: Zinforo/Teflaro, Dalbavancin, Others
- Roche: Rocephin
- Sanofi: Targocid, Others
- STADA Arzneimittel: Amoxicillin, Diclofenac Sodium
- This report provides analysis of the leading antibiotic drugs manufacturers in Japan, including forecasts from 2018-2028 of the company's antibiotic drugs revenues, where possible:
- Shionogi & Co., Ltd.: Flomox/Flumarin, Others
- Taisho Pharmaceutical Holdings: Geninax, Biaxin/Clarith, Zosyn/Tazocin
- Daiichi Sankyo: Cravit, Levaquin, Others
- Meiji Holdings Company, Ltd.: Meiact/Spectracef, Others
- Astellas Pharma: Dificid, Others
- This report provides analysis of the leading antibiotic drugs manufacturers in other countries, including forecasts from 2018-2028 of the company's antibiotic drugs revenue, where possible:
- Sun Pharmaceutical Industries: Ciprofloxacin Hydrochloride, Others
- Cipla: Amoxicillin, Others
- Lupin: Cefixime, Cephalexin, Others
- Shanghai Pharmaceuticals Holding: Cefotaxime Sodium, Cefotiam Hydrochloride, Ceftriaxone Sodium
- Dr. Reddy's Laboratories: Cefotaxime Sodium, Cefotiam Hydrochloride, Ceftriaxone Sodium
- TaiGen Biotechnology: Taigexyn
Read the full report: https://www.reportlinker.com/p05482466
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article